# Vyome Holdings, Inc: filings

HIND · Nasdaq · CIK 1427570 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hind.md) · [Financials](/companies/hind/financials.md) · [Filings](/companies/hind/filings.md) · [Insiders](/companies/hind/insiders.md)

## Reports and events: 240 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 199, 8-K 150, 3 42, 10-Q 30, CORRESP 29, 425 20, UPLOAD 19, SC 13G/A 18, EFFECT 16, S-1/A 16, 10-K 10, 424B3 10, 424B5 10, DEF 14A 9, S-8 9, SC 13G 9, S-1 8, S-3 7, PRE 14A 6, S-4/A 6, SCHEDULE 13G 6, D 5, SC 13D/A 5, 424B4 4, DEFA14A 4, SC 13D 4, SCHEDULE 13G/A 4, 8-K/A 3, NT 10-K 3, NT 10-Q 3, RW 3, 10-K/A 2, 4/A 2, DRS 2, FWP 2, S-1MEF 2, S-4 2, 10-Q/A 1, 8-A12B 1, CERTNAS 1, CT ORDER 1, DEL AM 1, POS AM 1, PRER14A 1, RW WD 1, S-3/A 1, SCHEDULE 13D 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-28 | 16:31 ET | [8-K](/filings/0001213900-26-095093.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-095093 |
| 2026-08-25 | 16:05 ET | [8-K](/filings/0001213900-26-093512.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-093512 |
| 2026-08-12 | 16:32 ET | [10-Q](/filings/0001213900-26-088402.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088402 |
| 2026-05-29 | 08:42 ET | [8-K](/filings/0001213900-26-062458.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-062458 |
| 2026-05-12 | 16:03 ET | [10-Q](/filings/0001213900-26-055058.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055058 |
| 2026-04-29 | 16:16 ET | [8-K](/filings/0001213900-26-049312.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-049312 |
| 2026-03-31 | 06:03 ET | [DEF 14A](/filings/0001213900-26-036740.md) | Proxy statement, period 2026-04-24 | 0001213900-26-036740 |
| 2026-03-18 | 06:38 ET | [10-K](/filings/0001213900-26-029500.md) | Annual report, period 2025-12-31 | 0001213900-26-029500 |
| 2026-02-25 | 16:15 ET | [8-K](/filings/0001213900-26-020387.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-020387 |
| 2026-02-13 | 21:16 ET | [8-K](/filings/0001213900-26-015795.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-015795 |
| 2026-01-28 | 09:00 ET | [8-K](/filings/0001213900-26-008575.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-008575 |
| 2025-12-23 | 16:10 ET | [8-K](/filings/0001213900-25-125310.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-125310 |
| 2025-11-19 | 17:21 ET | [8-K](/filings/0001213900-25-112728.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-112728 |
| 2025-11-14 | 16:51 ET | [10-Q](/filings/0001213900-25-110980.md) | Quarterly report, period 2025-09-30 | 0001213900-25-110980 |
| 2025-10-30 | 16:02 ET | [8-K](/filings/0001213900-25-104121.md) | 5.07 Shareholder vote results | 0001213900-25-104121 |
| 2025-10-06 | 06:16 ET | [DEF 14A](/filings/0001213900-25-096266.md) | Proxy statement, period 2025-10-28 | 0001213900-25-096266 |
| 2025-10-03 | 16:44 ET | [8-K](/filings/0001213900-25-096156.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-096156 |
| 2025-09-12 | 16:10 ET | [8-K/A](/filings/0001213900-25-087217.md) | 9.01 Financial statements and exhibits | 0001213900-25-087217 |
| 2025-09-02 | 08:04 ET | [8-K](/filings/0001213900-25-082924.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-082924 |
| 2025-08-20 | 17:23 ET | [8-K](/filings/0001213900-25-079045.md) | 1.01 Entry into a material agreement; 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-079045 |
| 2025-08-19 | 17:29 ET | [8-K](/filings/0001213900-25-078603.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-25-078603 |
| 2025-08-14 | 17:20 ET | [10-Q](/filings/0001558370-25-011594.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011594 |
| 2025-08-11 | 16:05 ET | [8-K](/filings/0001104659-25-076151.md) | 5.07 Shareholder vote results | 0001104659-25-076151 |
| 2025-07-25 | 16:06 ET | [8-K](/filings/0001104659-25-070826.md) | 5.07 Shareholder vote results | 0001104659-25-070826 |
| 2025-07-15 | 16:06 ET | [8-K](/filings/0001104659-25-068082.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-068082 |
| 2025-07-03 | 16:05 ET | [8-K](/filings/0001104659-25-065782.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-065782 |
| 2025-06-18 | 17:17 ET | [8-K](/filings/0001104659-25-060706.md) | 8.01 Other events | 0001104659-25-060706 |
| 2025-06-12 | 16:18 ET | [8-K](/filings/0001104659-25-058888.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-058888 |
| 2025-06-09 | 11:27 ET | [8-K](/filings/0001104659-25-057670.md) | 8.01 Other events | 0001104659-25-057670 |
| 2025-05-30 | 16:07 ET | [8-K](/filings/0001104659-25-054876.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-054876 |
| 2025-05-30 | 16:03 ET | [8-K](/filings/0001104659-25-054856.md) | 3.01 Delisting notice | 0001104659-25-054856 |
| 2025-05-28 | 07:00 ET | [8-K](/filings/0001104659-25-053285.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-053285 |
| 2025-05-20 | 16:56 ET | [10-Q](/filings/0001558370-25-008031.md) | Quarterly report, period 2025-03-31 | 0001558370-25-008031 |
| 2025-05-09 | 16:04 ET | [8-K](/filings/0001104659-25-046717.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-046717 |
| 2025-04-28 | 16:05 ET | [8-K](/filings/0001104659-25-040184.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-040184 |
| 2025-04-21 | 16:11 ET | [8-K](/filings/0001104659-25-036837.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-036837 |
| 2025-04-04 | 16:10 ET | [10-K](/filings/0001558370-25-004477.md) | Annual report, period 2024-12-31 | 0001558370-25-004477 |
| 2025-04-04 | 12:00 ET | [SCHEDULE 13D/A](/filings/0001753926-25-000576.md) | Ownership report, active investor, amended | 0001753926-25-000576 |
| 2025-04-02 | 07:21 ET | [8-K](/filings/0001104659-25-030900.md) | 5.07 Shareholder vote results | 0001104659-25-030900 |
| 2025-03-20 | 16:05 ET | [8-K](/filings/0001104659-25-026123.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-026123 |
| 2025-03-14 | 16:35 ET | [DEF 14A](/filings/0001104659-25-023989.md) | Proxy statement, period 2025-04-01 | 0001104659-25-023989 |
| 2025-02-20 | 16:05 ET | [8-K](/filings/0001104659-25-015658.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-015658 |
| 2025-02-14 | 15:58 ET | [S-1/A](/filings/0001104659-25-014018.md) | Registration statement, amended | 0001104659-25-014018 |
| 2025-02-14 | 06:24 ET | [S-1/A](/filings/0001104659-25-013174.md) | Registration statement, amended | 0001104659-25-013174 |
| 2025-02-13 | 06:21 ET | [S-1/A](/filings/0001104659-25-012392.md) | Registration statement, amended | 0001104659-25-012392 |
| 2025-02-07 | 17:22 ET | [S-1/A](/filings/0001104659-25-010613.md) | Registration statement, amended | 0001104659-25-010613 |
| 2025-02-06 | 06:46 ET | [S-1/A](/filings/0001104659-25-009814.md) | Registration statement, amended | 0001104659-25-009814 |
| 2025-01-21 | 16:05 ET | [8-K](/filings/0001104659-25-004884.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-004884 |
| 2025-01-21 | 06:06 ET | [S-1](/filings/0001104659-25-004648.md) | Registration statement | 0001104659-25-004648 |
| 2025-01-15 | 06:18 ET | [S-1/A](/filings/0001104659-25-003522.md) | Registration statement, amended | 0001104659-25-003522 |

Page 1 of 5. [Older](/companies/hind/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.